Promising Schizophrenia Drug, Cobenfy, Will Likely Face Access Challenges
Insurer access challenges likely lie ahead for the novel schizophrenia drug Cobenfy, given its considerably higher price than ...
Monthly Prescribing Reference1y
Abilify Asimtufii
Patients receiving Abilify Maintena: 960mg once every 2 months; may administer in place of next scheduled inj; reduce to 720mg once every 2 months if adverse reactions occur. Dose adjustments for ...
Yahoo Finance3d
Proposed Settlement Reached in the Canadian ABILIFY® and ABILIFY MAINTENA® Class Actions
Settlement Approval Hearings Scheduled in Ontario and Québec for December 20, 2024 and January 8, 2025 and Certification of Ontario Action This notice was approved by the Ontario Superior Court of ...
Hackaday2y
Smart Pills Can Tell Your Doctor That You’ve Taken Them
Credit: Proteus.com via Internet Archive. Perhaps the most well-known example is the medication known as Abilify MyCite, approved by the FDA in 2017. It’s a treatment that consists of an ...
Health Digest on MSN9mon
The Rexulti Commercial Explained: Drug Uses, Side Effects, And More
How Does Rexulti Differ From Abilify Or Latuda? Rexulti is a medication used to treat schizophrenia and is considered an ...
pharmaphorum3d
Abilify MyCite and innovating in digital health
A drug-device combination, Abilify MyCite was approved by the US regulator for schizophrenia, acute treatment of manic and mixed episodes associated with bipolar I disorder, and as an add-on ...